LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

Search

Omnicell Inc

Aperta

SettoreSettore sanitario

32.77 2.34

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

32.02

Massimo

32.79

Metriche Chiave

By Trading Economics

Entrata

13M

5.6M

Vendite

21M

291M

P/E

Media del settore

66.18

35.724

EPS

-0.151

Margine di Profitto

1.941

Dipendenti

3,650

EBITDA

42M

30M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+30.06% upside

Dividendi

By Dow Jones

Utili prossimi

29 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

162M

1.5B

Apertura precedente

30.43

Chiusura precedente

32.77

Notizie sul Sentiment di mercato

By Acuity

50%

50%

167 / 371 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Omnicell Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 set 2025, 23:07 UTC

Acquisizioni, Fusioni, Takeovers

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2 set 2025, 22:10 UTC

I principali Market Mover

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2 set 2025, 21:47 UTC

Utili

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2 set 2025, 16:52 UTC

I principali Market Mover

CleanCore Solutions Shares Drop After $175 Million Private Investment

2 set 2025, 22:47 UTC

Discorsi di Mercato

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2 set 2025, 21:40 UTC

Acquisizioni, Fusioni, Takeovers

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2 set 2025, 21:07 UTC

Utili

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2 set 2025, 21:07 UTC

Utili

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2 set 2025, 21:05 UTC

Utili

Couche-Tard 1Q Rev $17.35B >ATD.T

2 set 2025, 21:05 UTC

Utili

Couche-Tard 1Q Adj EPS 78c >ATD.T

2 set 2025, 21:05 UTC

Utili

Couche-Tard 1Q EPS 82c >ATD.T

2 set 2025, 21:05 UTC

Utili

Couche-Tard 1Q Net $782.5M >ATD.T

2 set 2025, 21:00 UTC

Discorsi di Mercato

ESG Roundup: Market Talk

2 set 2025, 20:53 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2 set 2025, 20:51 UTC

Acquisizioni, Fusioni, Takeovers

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2 set 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

2 set 2025, 20:27 UTC

Utili

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2 set 2025, 20:24 UTC

Acquisizioni, Fusioni, Takeovers

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2 set 2025, 20:18 UTC

Acquisizioni, Fusioni, Takeovers

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2 set 2025, 20:17 UTC

Acquisizioni, Fusioni, Takeovers

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2 set 2025, 20:16 UTC

Acquisizioni, Fusioni, Takeovers

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2 set 2025, 20:16 UTC

Acquisizioni, Fusioni, Takeovers

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2 set 2025, 20:15 UTC

Acquisizioni, Fusioni, Takeovers

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2 set 2025, 19:55 UTC

Utili

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2 set 2025, 19:50 UTC

Acquisizioni, Fusioni, Takeovers

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2 set 2025, 19:09 UTC

Discorsi di Mercato

Oil Futures Gain on Geopolitical Premium -- Market Talk

2 set 2025, 19:00 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2 set 2025, 18:12 UTC

Discorsi di Mercato

Gold Pushes To New Record -- Market Talk

2 set 2025, 17:04 UTC

Discorsi di Mercato

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2 set 2025, 16:57 UTC

Acquisizioni, Fusioni, Takeovers

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Confronto tra pari

Modifica del prezzo

Omnicell Inc Previsione

Obiettivo di Prezzo

By TipRanks

30.06% in crescita

Previsioni per 12 mesi

Media 41.75 USD  30.06%

Alto 55 USD

Basso 32 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Omnicell Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

6 ratings

4

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

24.23 / 30.44Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

167 / 371 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.